SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,668,600 | +1254.3% | 368,492 | +1179.5% | 1.06% | +1375.0% |
| Q2 2023 | $3,298,176 | -86.1% | 28,800 | -83.2% | 0.07% | -85.2% |
| Q1 2023 | $23,660,311 | +3854.8% | 171,663 | +3618.1% | 0.48% | +3364.3% |
| Q4 2022 | $598,271 | -62.8% | 4,617 | -68.3% | 0.01% | -65.0% |
| Q3 2022 | $1,609,000 | +35.1% | 14,561 | -8.4% | 0.04% | +29.0% |
| Q2 2022 | $1,191,000 | -69.2% | 15,890 | -63.0% | 0.03% | -65.9% |
| Q4 2021 | $3,872,000 | +16.3% | 43,000 | +19.4% | 0.09% | -1.1% |
| Q3 2021 | $3,329,000 | +665.3% | 36,000 | +542.9% | 0.09% | +557.1% |
| Q2 2021 | $435,000 | +86.7% | 5,600 | +186.0% | 0.01% | -39.1% |
| Q1 2019 | $233,000 | -77.7% | 1,958 | -93.7% | 0.02% | -89.4% |
| Q2 2017 | $1,045,000 | -3.5% | 31,000 | -15.3% | 0.22% | +7.4% |
| Q1 2017 | $1,083,000 | +286.8% | 36,600 | +258.8% | 0.20% | +215.6% |
| Q4 2016 | $280,000 | -41.8% | 10,200 | +30.3% | 0.06% | -38.5% |
| Q3 2016 | $481,000 | -49.0% | 7,830 | -83.8% | 0.10% | -71.2% |
| Q1 2016 | $943,000 | – | 48,300 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |